Kurzfassung

Within the collaborative research center ‘Nanodimensional polymer therapeutics for tumor therapy’ (SFB 1066) this project (Q3) investigates pharmacokinetics, metabolism and drug release of radiolabeled particles from A- and B-projects by means of PET imaging. Additionally, ferromagnetic particles will be quantified in tissue by MRI and hybrid imaging for functional-anatomical co-registration by PET/MRI will be established. Glucose metabolism measured with FDG-PET will serve as method to...Within the collaborative research center ‘Nanodimensional polymer therapeutics for tumor therapy’ (SFB 1066) this project (Q3) investigates pharmacokinetics, metabolism and drug release of radiolabeled particles from A- and B-projects by means of PET imaging. Additionally, ferromagnetic particles will be quantified in tissue by MRI and hybrid imaging for functional-anatomical co-registration by PET/MRI will be established. Glucose metabolism measured with FDG-PET will serve as method to quantify effects of the new therapeutic regimens on tumor tissue and immune system over time.» weiterlesen» einklappen